If you have a Facebook account we strongly recommend you to BioMedReports.com is the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors has Healthcare stock news and updates to its calendar ...

guest published in:05-03   reply:0   view:5    last updated:05-03 07:29( guest )

InvestorIdeas.com a global investor research portal for independent investors features an investor FAQ and Fact Sheet for specialty pharmaceutical company BioSante Pharmaceuticals Inc: (NASDAQ: BPAX). Date Released: 08/26/2011 Investor FAQs and Facts for BioSante Pharmaceuticals Inc: (NASDAQ: ...

guest published in:10-07   reply:0   view:18    last updated:10-07 13:29( guest )

Northern WI 8/23/2011 (PennyPayDay) -- www.InvestorIdeas.com a global investor research portal for independent investors features an investor FAQ and Fact Sheet for specialty pharmaceutical company BioSante Pharmaceuticals Inc: (NASDAQ: BPAX). BioSantes (NASDAQ: BPAX) stock has built a sig ...

guest published in:09-13   reply:0   view:24    last updated:09-13 06:29( guest )

Investor FAQs and Facts for BioSante Pharmaceuticals Inc: (NASDAQ: BPAX) POINT ROBERTS August 24 2001 www.InvestorIdeas.com a global investor research portal for independent investors features an investor FAQ and Fact Sheet for specialty pharmaceutical company BioSante Pharmaceuticals Inc ...

guest published in:09-09   reply:0   view:31    last updated:09-09 04:30( guest )

Easton Pharmaceuticals Announces VIORRA Regulatory Filing in Mexico: Expected to be First Territory Launch Easton Pharmaceuticals Could Be On The Market In Mexico by Q1 2012 Regional Sales Marketing Partner Candidates Targeted TORONTO ONTARIO (GenesisStockWatch.com) Easton Pharmaceuticals ( ...

guest published in:08-10   reply:0   view:28    last updated:08-10 10:29( guest )

author:admin    comment:0   view:3   userful 1

Furiex Pharmaceuticals Inc. announced that it has entered into an agreement with ALZA Corporation and Janssen Pharmaceutica N.V. whereby ALZA and Janssen will transfer worldwide rights for Priligy to Furiex.

author:admin    comment:0   view:3   userful 1

Furiex Pharmaceuticals Inc. and Menarini Group today announced that they have entered into a license agreement by which Furiex will license to Menarini rights to commercialize Priligy in Europe most of Asia Africa Latin America and the Middle East.

author:admin    comment:0   view:3   userful 1

BioSante Pharmaceuticals Inc. today reported on its financial results for the first quarter of 2012 and cash balance as of March 31 2012.

author:admin    comment:0   view:4   userful 1

TORONTO ONTARIO-- - Trimel Pharmaceuticals Corporation today reported its financial results for the three month period ended March 31 2012. The Company also provided investors today with an update on ...

author:admin    comment:0   view:8   userful 1

GREENWOOD VILLAGE Colo. and GOIANIA GOIAS Brazil March 22 2012 /PRNewswire/ -- Ampio Pharmaceuticals Inc. (NASDAQ: AMPE - News) ("Ampio" or the "Company") a company that discovers and ...